1/2 -Macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese

Neurology

Volumn 54, Issue 2, 2000, Pages 443-446

  Sodeyama, N ^c   Yamada, Masahito ^b   Itoh, Y ^c   Suematsu, N ^c   Matsushita, M ^a   Otomo, E ^c   Mizusawa, H ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

AD; Apolipoprotein E; Japanese; Neurofibrillary tangle; Neuropathologic change; Risk factor; Senile plaque; 2 Macroglobulin Polymorphism

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; JAPAN; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE; ALLELE; ASIAN; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HIPPOCAMPUS; MIDDLE AGED; NEUROFIBRILLARY TANGLE; PATHOLOGY; RISK FACTOR; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALLELES; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIPPOCAMPUS; HUMANS; JAPAN; MIDDLE AGED; NEUROFIBRILLARY TANGLES; POLYMORPHISM, GENETIC; RISK FACTORS; SENILE PLAQUES; TEMPORAL LOBE;

EID: 0034711621     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.2.443     Document Type: Article

References (28)

1. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14.
2. Sodeyama N, Itoh Y, Suematsu N, et al. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;64:548-551.
3. Sodeyama N, Yamada M, Itoh Y, et al. Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with Alzheimer-type neuropathological changes or sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:221-225.
4. Wragg M, Hutton M, Talbot C, the Alzheimer's disease Collaborative Group. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512.
5. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE*4-associated Alzheimer's disease risk is modified by alantichymotrypsin polymorphism. Nat Genet 1995;10:486-488.
6. Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet 1997;6:1933-1936.
7. Wavrant-DeVrièze F, Pérez-Tur J, Lambert J-C, et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997;227: 68-70.
8. 2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptides via cell surface low-density lipoprotein receptor-related protein. J Neurochem 1997;69:1904-1911.
9. Ganter U, Strauss S, Jonas U, et al. Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells: potential significance for the processing of Alzheimer β-amyloid precursor protein. FEBS Lett 1991;282:127-131.
10. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 1995; 37:211-217.
11. 2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 1998;95:3275-3280.
12. 2-Macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 1998;70:1182-1188.
13. Wood JA, Wood PL, Ryan R, et al. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. Brain Res 1993;629: 245-252.
14. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B. Detection of interleukin-6 and α2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992;66:223-230.
15. Blacker D, Wilcox MA, Laird NM, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. Nat Genet 1998;19:357-360.
16. Liao A, Nitsch RM, Greenberg SM, et al. Genetic association of an α2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease. Hum Mol Genet 1998;7:1953-1956.
17. Kan C-C, Solomon E, Belt KT, Chain AC, Hiorns LR, Fey G. Nucleotide sequence of cDNA encoding human αt2-macroglobulin and assignment of the chromosomal locus. Proc Natl Acad Sci USA 1985;82:2282-2286.
18. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12. JAMA 1997;278: 1237-1241.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington DC: American Psychiatric Association, 1987.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
22. Yamada M, Itoh Y, Otomo E, Suematsu N, Matsushita M. Dementia of the Alzheimer type and related dementias in the aged: DAT subgroups and senile dementia of the neurofibrillary tangle type. Neuropathology 1996;16:89-98.
23. Matthijs G, Marynen P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucleic Acids Res 1991;19:5102.
24. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhoI. J Lipid Res 1990;31:545-548.
25. Dow DJ, Lindsey N, Cairns NJ, et al. α-2 Macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet 1999;22:16-17.
26. Rudrasingham V, Wavrant-De Vrièze F, Lambert J-C, et al. α-2 Macroglobulin gene and Alzheimer disease. Nat Genet 1999;22:17-19.
27. Rogaeva EA, Premkumar S, Grubber J, et al. An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet 1999;22:19-21.
28. Wavrant-DeVrièze F, Rudrasingham V, Lambert J-C, et al. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci Lett 1999; 262:137-139.